Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-12-20 00:00:00 ET · period of report 2022-12-16 · accession 0001493152-22-035990 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-20 | 2022-12-01 | IMDX | Paulsen Gisela | COO, Former Pres | D - Sale to Iss | $0.00 | -175.0K | 366.5K | -32% | $0 |
| DM | 2022-12-20 | 2022-12-16 | IMDX | Paulsen Gisela | COO, Former Pres | D - Sale to Iss | $0.00 | -367.2K | 203.1K | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-12-01 | D | D | 175,000 | $0.00 | 366,500 | D | — | — | (F1) The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022. |
| 2 | Derivative | Option to Purchase Common Stock | 2022-12-16 | D | D | 70,313 | $0.00 | 54,687 | D | $1.15 · — to — | 70,313 Common Stock | (F2) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022. |
| 3 | Derivative | Option to Purchase Common Stock | 2022-12-16 | D | D | 125,000 | $0.00 | 0 | D | $1.15 · — to — | 125,000 Common Stock | (F2) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022. |
| 4 | Derivative | Option to Purchase Common Stock | 2022-12-16 | D | D | 171,875 | $0.00 | 203,125 | D | $3.42 · — to — | 171,875 Common Stock | (F2) The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022. |